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Abstract 
Daptomycin is a lipopeptide antibiotic that binds to and depolarizes bacterial cell membranes. Its 
antibacterial activity requires calcium and correlates with the content of phosphatidylglycerol in 
the target membrane. Daptomycin has been shown to form oligomers on liposome membranes. 
We here use perylene excimer fluorescence to further characterize the membrane-associated 
oligomer. To this end, the N-terminal fatty acyl chain was replaced with perylene-butanoic acid. 
The perylene derivative retains one third of the antibacterial activity of native daptomycin. On 
liposomes containing phosphatidylcholine and phosphatidylglycerol, as well as on Bacillus 
subtilis cells, the perylene-labeled daptomycin forms excimers, which shows that the N-terminal 
acyl chains of neighboring oligomer subunits are in immediate contact with one another. In a 
lipid bicelle system, oligomer formation can be titrated with stoichiometric amounts of 
phosphatidylglycerol. Therefore, the interaction of daptomycin with a single molecule of 
phosphatidylglycerol is sufficient to trigger daptomycin oligomerization.  
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Introduction 
Daptomycin is a cyclic lipopeptide that consists of 13 amino acid residues, including one 
kynurenine residue and several other non-standard amino acids, and a decanoyl fatty acyl residue 
attached to the exocyclic N-terminal tryptophan residue (see Figure 1). It is produced by the soil 
bacterium Streptomyces roseosporus. Daptomycin is used in the treatment of infections by Gram-
positive bacteria such as enterococci and staphylococci, including strains that are resistant to 
penicillin, methicillin and vancomycin [1, 2]. Daptomycin binds and depolarizes the bacterial 
cytoplasmic membrane [3]. Its activity requires calcium and correlates with the target 
membrane's content of phosphatidylglycerol (PG); increased conversion of PG to lysyl-PG 
confers partial resistance to bacterial cells [4, 5].  
Using FRET between the kynurenine residue of unlabeled daptomycin and a fluorescently 
labeled derivative of daptomycin, we have shown before that daptomycin forms oligomers on 
liposome membranes [6]. Oligomerization occurs under conditions that resemble those required 
for its antibacterial activity, suggesting that the oligomer is involved in the bactericidal effect.  
In this study, we have used excimer fluorescence in order to further characterize the membrane-
associated daptomycin oligomer. An excimer, or excited dimer, is a complex that forms from one 
fluorophore molecule that is in the excited state and another one in the ground state [7]. Since this 
requires direct contact between two fluorophore molecules, the detection of excimer fluorescence 
imposes a more stringent constraint on the distance of the interaction than that implied by the 
observation of FRET. 
The fluorophore most widely used to study excimer fluorescence is pyrene, whose excimer and 
monomer spectra are well separated. However, when pyrene was incorporated into daptomycin, 
we observed that most pyrene fluorescence was lost due to energy transfer to kynurenine. We 
therefore chose to incorporate perylene, which emits at longer wavelengths [8] and therefore 
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should not engage in FRET to kynurenine.  
A prior study has shown that substitutions of the N-terminal decanoyl moiety of daptomycin are 
quite compatible with its antibacterial activity, as long as the introduced substituents retain an 
overall hydrophobic character [9]. Pyrene and perylene are very hydrophobic molecules, and 
accordingly they were introduced into daptomycin by replacing the decanoyl chain with pyrene-
butanoic acid and perylene-butanoic acid, respectively. The derivatives retained antibacterial 
activity, albeit at a slightly reduced level in the case of perylene-daptomycin. Nevertheless, 
oligomer formation of perylene-daptomycin was clearly evident through excimer fluorescence, 
under conditions that mirrored those use in the previous FRET experiments. This result indicates 
that the fatty acyl residues of adjacent subunits of the membrane-associated daptomycin oligomer 
are within immediate reach of one another.  
In a lipid bicelle system, the excimer fluorescence could be titrated with phosphatidylglycerol. 
Conversion of monomer fluorescence to excimer fluorescence approached saturation at an 
equimolar ratio of phosphatidylglycerol to daptomycin. Therefore, a single molecule of 
phosphatidylglycerol is sufficient to convert daptomycin to a conformation that is competent for 
oligomerization. 
Our study provides significant additional insight into the process of daptomycin oligomerization. 
At the same time, it demonstrates that perylene excimer fluorescence is useful as a probe in the 
experimental study of biochemical systems.  
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Materials and Methods 
Synthesis of perylene-daptomycin. To a suspension of deacylated daptomycin bearing a Boc 
protecting group on the ornithine residue (120 mg, 0.077 mmol; generously provided by Jared 
Silverman of Cubist Inc.) in dry dimethylformamide (0.5 mL) was added 4-(3-perylenyl)butanoic 
acid succinimidyl ester (see supporting information; 0.035g, 0.08 mmol). The mixture was stirred 
for 24 h and then concentrated by high vacuum rotary evaporation. The residue was dissolved in 
water and lyophilized. The lyophilized powder was dissolved in an ice cold solution of 
trifluoroacetic acid (TFA) containing 2% thioanisole, and the resulting solution was stirred for 15 
minutes at 0 ºC (ice bath). The mixture was concentrated using a high vacuum rotary evaporator, 
keeping the heating bath below 40 ºC. The residue was dissolved in water and lyophilized. The 
resulting crude powder was purified by semi-preparative reversed phase HPLC employing a 
linear gradient starting with 95% water (0.1% TFA)-5% acetonitrile to 100 % acetonitrile over 50 
minutes (tr=34 min). Fractions containing the desired product were pooled and concentrated 
using a high vacuum rotary evaporator keeping the heating bath below 40 ºC. The resulting 
residue was lyophilized to give 0.047 g (34% yield) of perylene-daptomycin as a yellow powder. 
-
ESIMS: 1784.76 (M-H)
-1
 (Figure S1). The analytical reversed-phase HPLC chromatogram of the 
purified material, using a linear gradient starting with 95% water (0.1% TFA)-5% acetonitrile to 
100 % acetonitrile over 50 minutes is shown in Figure S2. 
Synthesis of pyrene-daptomycin. This compound was prepared using the same procedure as that 
described above for perylene-daptomycin using 0.0081 g (0.021 mmol) 1-pyrenebutanoic acid 
succinimidyl ester and 0.030 g (019 mmol) deacylated daptomycin bearing a Boc protecting 
group on the ornithine residue. The crude product was purified by HPLC as described above for 
perylene-daptomycin (tr=28 min). Fractions containing the desired product were pooled and 
concentrated and the resulting residue lyophilized to give 17 mg (51% yield) of pyrene-
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daptomycin as a white powder. 
-
ESIMS: 1734.75 (M-H)
-1
 (Figure S3). The analytical reversed-
phase HPLC chromatogram of the purified material using the conditions described above for 
perylene-daptomycin is shown in Figure S4. 
Antibacterial activity test for pyrene- and perylene-daptomycin. The two labeled derivatives as 
well as native daptomycin were tested for antibacterial activity by broth dilution. LB broth was 
supplemented with calcium (5 mM), and the daptomycin derivative in question was added at 
concentrations of 10, 5, 3, 2, 1.5, and 1 μg/ml. Each tube was inoculated with Bacillus subtilis 
ATCC 1046 and incubated overnight at 37 ºC. Growth inhibition was evaluated visually by 
turbidity. Growth controls without antibiotic were prepared for comparison. 
Preparation of large unilamellar vesicles (LUV). 1,2-Dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1-palmitoyl-2-
oleoyl-sn-glycerol-3-phosphoethanol (POPE), 1,2-dioleoyl-sn-glycerol-3-phospho-(1-rac-
glycerol) (DOPG), and 1,3-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (tetra-oleyl-
cardiolipin; TOCL) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). The 
required amounts of DMPC and DMPG, or of POPE, DOPG and cardiolipin, were weighted, 
dissolved in chloroform and transferred to a round-bottom flask. The solvent was evaporated with 
nitrogen and the resulting lipid films further dried under vacuum for three hours. The lipids were 
then suspended in HEPES 20 mM, pH 7.4, NaCl 150 mM (HBS). Finally, the suspension was 
extruded 10-15 times through 100 nm polycarbonate filters, using a nitrogen-pressurized 
extrusion device [10]. The liposomes were employed in the fluorescence experiments at a final 
concentration of 250 μM total lipid.  
Fluorescence measurements. Emission spectra were acquired on a QuantaMaster 4 
spectrofluorimeter (Photon Technology International, London, ON). Pyrene fluorescence was 
excited at 340 nm and the emission recorded from 360 to 600 nm. Perylene fluorescence was 
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excited at 430 nm and the emission recorded from 440 to 600 nm. Bandpasses for excitation and 
emission were between 2 and 5 nm, depending on the sample concentration. Emission spectra 
were corrected for wavelength-dependent instrument response using a quinine sulfate standard 
and a tabulated normalized quinine spectrum listed in [7]. 
Fluorescence lifetime measurements were performed on a FluoTime 100 Lifetime spectrometer 
(PicoQuant, Berlin, Germany), using diode laser light sources emitting at 370 nm and at 440 nm 
for pyrene and perylene, respectively. The emission was isolated using 460±10 nm or 560±10 nm 
bandpass filters (Melles-Griot, Brossard, QC). Experimental decays were numerically fitted with 
two or three exponentials, with resulting χ2 values typically between 1.1 and 1.3. From these 
fitted exponential components, average lifetimes were calculated according to the equation 
〈τ 〉=
∑ αi τ i
2
∑ αi τ i  
were αi represents the amplitude at time zero and τi the lifetime of the i
th
 component. 
All measurements were acquired at room temperature. The concentration of calcium was 200 mM 
with liposomes consisting of PC only. With all other samples, the calcium concentration was 5 
mM unless stated otherwise.  
Deconvolution of perylene excimer and monomer spectra. Perylene fluorescence decays were 
measured at 560±10 nm on DMPC/DMPG membranes, both with pure perylene-daptomycin and 
with a mixture of perylene-daptomycin and a fivefold excess of unlabeled daptomycin. The 
decays were fitted to a two-exponential model. The fractional emission intensities of the 
monomer and the excimer at 560 nm were obtained from these data according to  
F monomer,560=
α1τ 1
α1 τ1+α2 τ2 and 
F excimer,560= 1− Fmonomer,560  
From the spectrum of perylene-daptomycin only, P, and the spectrum of the mixture of perylene-
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daptomycin with unlabeled daptomycin, U, the pure excimer spectrum, E, was calculated as 
E=P− aU  
with  
a=
F P,monomer,560 I P,560
F U,monomer,560 I U, 560  
where 
I
P,560 and 
I
U, 560  denote the intensity of P and U at 560 nm, respectively. The pure 
monomer spectrum M was obtained analogously. After normalizing E and M to the same quantity 
of molecules, the quantum yield of the excimer, relative to that of the monomer, was calculated 
from the ratio of the areas of the two normalized spectra.  
Titration of perylene excimer fluorescence with phosphatidylglycerol. To a solution of 100 μM 
perylene-daptomycin, 1 mM Ca
++
 and 20 mM DHPC in HBS, a mixture of DMPC and DMPG 
(molar ratio, 4:1) was added in a stepwise fashion. After each addition, the mixture was incubated 
for 2 minutes before acquisition of the perylene emission spectrum. Repeated scans showed that 
this short incubation sufficed to reach equilibrium. From each spectrum, the ratio of the emission 
intensities at 521nm and 480 nm was calculated, and the increment was plotted as a function of 
the molar ratio of DMPG to perylene-daptomycin. 
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Results 
Synthesis and purification of pyrene- and perylene-daptomcyin. The synthetic procedure, as well 
as mass spectrometry and chromatography data on the product are given in the supplementary 
information file. The structures of pyrene- and perylene-daptomycin are shown in Figure 1.  
Antibacterial activity of pyrene- and perylene-daptomycin. The antibacterial activity of pyrene- 
and perylene-daptomycin against Bacillus subtilis strain ATCC 1046 was determined by broth 
dilution,  using native daptomycin as a reference. The minimum inhibitory concentration of 
perylene-daptomycin was 3 μg/ml, compared to 1 μg/ml for native daptomycin and pyrene-
daptomycin. Therefore, the specific activity of perylene-daptomycin is approximately 3 times 
lower than that of native daptomycin and of pyrene-daptomycin.  
Fluorescence of pyrene-daptomycin. Figure 2 shows the emission spectra of pyrene-daptomycin 
in solution and on liposomes consisting of phosphatidylcholine (PC) and phosphatidylglycerol 
(PG). Pyrene monomer fluorescence, which is apparent in the small peaks to both sides of 380 
nm, is very low in both samples. There is a broad peak around 460 nm that greatly increases after 
incubation with the liposomes, on which daptomycin has been shown to form oligomers.  
While oligomer formation should be accompanied by excimer formation, the latter should be 
accompanied by a decrease of monomer emission, which however is low to begin with and does 
not decrease any further. Furthermore, the peak at 460 nm has an average excited state lifetime of 
approximately 3.5 nanoseconds (data not shown), whereas the typical lifetimes of pyrene 
excimers are much longer. On the other hand, the observed lifetime is very similar to that found 
previously for the kynurenine residue of daptomycin [6].  
The monomer emission spectrum of pyrene significantly overlaps the absorption spectrum of the 
kynurenine residue, which should cause fluorescence energy transfer from excited pyrene to 
kynurenine. The increase in the sensitized kynurenine emission upon membrane binding mirrors 
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that of directly excited kynurenine fluorescence reported earlier [11]. 
In sum, because of spectral overlap between pyrene emission and kynurenine absorption, pyrene-
daptomycin does not produce experimentally useful excimer fluorescence. 
Observation of perylene-daptomycin excimer fluorescence. The emission spectrum of perylene-
daptomycin in solution resembles that of monomeric, free perylene in hexane [8], with three 
distinct peaks between 450 and 520 nm (Figure 3A). A similar spectrum is obtained when 
perylene-daptomycin is incubated with DMPC membranes (Figure 3B). In contrast, on 
membranes composed of DMPC and DMPG, as well as on bacterial cells, the shape of the 
spectrum changes significantly (Figure 3C, D). The two leftmost peaks are greatly decreased, and 
a new, broad peak emerges that overlaps the monomer fluorescence. While the new peak is 
centered around 525 nm and therefore is blue-shifted relative to the excimer of free perylene [8], 
its shape nevertheless is suggestive of excimer fluorescence. This interpretation is corroborated 
by time-resolved fluorescence measurements. Figure 4 shows the fluorescence decays measured 
at 560 nm of perylene-daptomycin on PC liposomes (A) and on PC/PG liposomes (B). Both 
decays can be fitted quite well with a two-exponential model (see fit parameter values in the 
figure), and the lifetime parameters obtained from these fits are similar to those of perylene 
monomers and excimers reported earlier [8]. Note that the pre-exponentials are different between 
the two membranes, which reflects a higher prevalence of excimers on the PC/PG membranes. 
Also, the fitted fluorescence lifetime of the putative excimer component is shorter in PC than in 
PC/PG membranes.  
Excimer fluorescence only occurs when a monomer in the excited state binds directly to a another 
monomer that is in the ground state. It should therefore be greatly facilitated by the formation of 
stable oligomers, since within these the perylene moieties should remain close to one another 
throughout. On the other hand, a mixture of perylene-daptomycin with an excess of unlabeled 
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daptomycin should produce hybrid oligomers, within which the perylene-labeled molecules 
should become separated from one another by intervening unlabeled molecules. This should lead 
to increased monomer fluorescence and decreased excimer fluorescence. Figure 5 shows that this 
is indeed the case. It also shows that, on PC membranes, the ratio of excimer fluorescence to 
monomer fluorescence is not affected by the addition of unlabeled daptomycin. This is in line 
with the assumption that stable oligomers do not form on these membranes, and that excimer 
fluorescence arises by diffusional collision of individual perylene-daptomycin molecules only.  
Very similar spectra and fluorescence lifetimes were obtained on liposomes consisting of POPE, 
DOPG and TOCL, which are considered models of the cytoplasmic membranes of bacteria [12, 
13]. This is in line with prior observations [6]. 
Quantitative evaluation of excimer fluorescence. By combining lifetime data with steady state 
spectra, we can obtain an approximation of the spectrum of the excimer, as well as an estimate of 
its quantum yield relative to that of the monomer. The calculation, which is detailed in the 
Methods section, yields the monomer and excimer spectra shown in Figure 6. The quantum yield 
of the excimer, relative to that of the monomer, is 0.35.  
On PC/PG membranes, the observed excimer emission corresponds to > 90% of all excitation 
events. If we neglect excimer emission due to collisional encounters of the few remaining 
monomers, we can infer that more than 90% of all daptomycin molecules are now located in 
oligomers. Considering that some excited perylene molecules will emit monomer fluorescence 
even when placed in the vicinity of other perylene molecules, the extent of oligomer formation 
may well be even higher.  
At an oligomerization efficiency of 90%, the ratio of emission at 521 nm to that at 482 nm is 1.35 
(Figure 3C). This ratio is 0.33 for PC liposomes (Fig. 3B), on which perylene-daptomycin emits 
mostly as a monomer. On bacterial cells (Fig. 3D), it is 1.16, which shows that most of the cell-
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bound perylene-daptomycin have become incorporated into oligomers. Therefore, on suitable 
membranes, oligomerization of daptomycin approaches or reaches completion.  
Titration of excimer fluorescence with phosphatidylglycerol. In previous studies [6, 11, 14], 
phosphatidylglycerol was used in considerable molar excess over daptomycin, and therefore 
these experiments did not provide information on the stoichiometry of the interaction of 
daptomycin with PG. To examine this question, we used a mixture of DMPC and DMPG with an 
excess of dihexanoyl-PC. Mixtures of the latter with lipids of typical acyl chain length yield lipid 
bicelles, which are small, disk-like lipid aggregates that are suitable as membrane mimetics [15]. 
The advantage of bicelles over liposomes is twofold. Firstly, suspensions of bicelles are much 
less turbid. This allows measurements at higher concentrations of daptomycin and PG, which will 
help to drive the reaction between the two toward completion. Secondly, in a bicelle, both 
monolayers will be exposed to daptomycin. In contrast, with liposomes, only the outer monolayer 
may be accessible. Previous observation of membrane fusion induced by daptomycin in model 
liposomes [14] suggests that the membrane continuity may be disrupted, and both monolayers 
may be accessible to daptomycin in this system also. On the other hand, membrane fusion did not 
go to completion. In addition, no morphological changes to the cell membranes of daptomycin-
treated bacteria were observed by electron  microscopy [16], suggesting that the inner monolayer 
me not or only incompletely accessible to daptomycin. Use of bicelles avoids this uncertainty.  
Figure 7 shows the titration of 100 μM perylene-daptomycin, in 20 mM dihexanoyl-PC and 1 
mM calcium, with a mixture of dimyristoyl-PC and dimyristoyl-PG. Excimer formation is 
monitored as the ratio of fluorescence intensities at wavelengths 521 nm and 482 nm. It can be 
seen that the extent of excimer formation, and thus oligomerization, approaches saturation after 
addition of a stoichiometric amount of phosphatidylglycerol.  
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Discussion 
In this study, we synthesized pyrene-daptomycin and perylene-daptomcyin and used the latter to 
characterize the oligomerization of daptomycin on membranes. The perylene moiety was 
introduced into daptomycin by substituting it for the normal decanoyl chain. Considering the 
substantial bulk that is added to the molecule by this modification, the fact that the antimicrobial 
activity is reduced no more than threefold is quite remarkable, as is the observation that the 
introduction of pyrene caused no measurable decrease in activity at all. These observations are, 
however, in line with a previous study on a variety of acyl analogues, which revealed only minor 
changes to the antibacterial activity, as long as the overall hydrophobic character of the acyl chain 
was preserved [9]. While the spectral overlap between pyrene and kynurenine prevented the 
observation of pyrene excimer fluorescence, excimers could be observed and used to characterize 
the oligomerization of daptomycin. 
The perylene excimer fluorescence indicated the formation of daptomycin oligomers on both 
liposomes and bacterial cells. In liposomes, oligomerization correlates with the presence of 
phosphatidylglycerol. These findings are entirely consistent with those of a previous study that 
used fluorescence energy transfer [6]. Beyond this confirmation, the use of perylene-daptomcyin 
provides significant additional insights that could not be inferred from previous experiments.  
The first novel observation is the formation of daptomycin oligomers on live bacterial cells. 
Secondly, using perylene-daptomcyin, the extent of oligomerization could be measured. This 
extent exceeds 90% on model membranes that contain 50% DMPG, and it is only slightly lower 
on bacterial membranes. This high extent of oligomerization supports the notion that it is the 
oligomer that causes the bactericidal effect. 
Thirdly, the formation of perylene excimers shows that, in the oligomer, the N-terminal acyl 
chains interact directly with one another. Direct interaction of the daptomycin peptide moieties 
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within the oligomer was previously inferred from the self-quenching of NBD-labels that had been 
attached to their ornithine residues [6]. Taken together, these two points of mutual interaction 
suggest that  neighboring oligomer subunits are aligned in a parallel fashion, or form an acute 
angle with one another.  
The fourth novel finding reported here is that daptomycin oligomerization is driven by a 
stoichiometric interaction with phosphatidylglycerol.  This result suggests that PG interacts with 
daptomycin directly and specifically, rather than indirectly through influencing bulk properties of 
the membrane such as charge or lateral phase segregation. Enhanced conversion of PG to lysyl-
PG by bacterial cells has been reported as a mechanism of partial resistance to daptomycin [4, 5], 
which supports the notion that PG-mediated oligomerization is essential for the activity of 
daptomycin. 
In summary, the current study provides significant new insights into the interaction of 
daptomycin with itself and with membrane lipids. At the same time, this study is the first one to 
use perylene excimer fluorescence for the characterization of peptide or protein oligomerization. 
The results provided here illustrate that perylene should be a valuable tool wherever the 
occurrence of intrinsic chromophores or fluorophores precludes the use of pyrene-labeled probes.  
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Legends to Figures 
Figure 1: Structure of daptomycin, and of the substituents pyrene- and perylene-butanoic acid 
that were substituted for the decanoyl residue of the native compound in this study. 
Figure 2: Fluorescence emission spectra of pyrene-daptomycin in solution and on DMPC/DMPG 
liposomes, in the presence of 6 mM calcium. The excitation wavelength was 340 nm. 
Figure 3: Fluorescence emission  spectra of perylene-daptomycin, in solution (A), on DMPC 
liposomes (B), on DMPC/DMPG liposomes (C), and on bacterial cells (D). The emission spectra 
were measured with 2.5 μM perylene-daptomycin. In (A), the absorption spectra of perylene-
daptomycin (PD) and of native daptomycin (ND) at 50 μM in solution are also shown. The 
absorption spectrum of native daptomycin on membranes is indistinguishable (not shown). In 
(D), the cells were incubated with perylene-daptomycin and calcium, then washed twice by 
centrifugation to remove unbound daptomycin and resuspended before acquisition of the 
spectrum.  
Figure 4: Time-resolved fluorescence measurements of perylene-daptomycin on DMPC (A) and 
DMPC/DMPG (B) membranes. Sample composition was as in Figure 3B and 3C, respectively. 
Excitation was with a 440 nm diode laser. Emission was measured using a 560±10 nm bandpass 
filter. The decays were fitted to a two-exponential model. Pre-exponentials (α) and lifetimes (τ) of 
the fitted components, as well as the residuals and χ2 of the fits are given.  
Figure 5: Effect of unlabeled daptomyin on the extent of excimer formation by perylene-
daptomycin. Perylene-daptomycin (2.5 μM) was mixed with unlabeled daptomycin at the molar 
ratios indicated and incubated with DMPG/DMPC or DMPC liposomes with 6 and 200 mM of 
calcium, respectively. The change in fluorescence is represented the ratio of emission at 521 nm 
over that at 482 nm; a higher ratio indicates a greater extent of excimer formation. 
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Figure 6: Deconvoluted excimer and monomer spectra of perylene-daptomycin on 
DMPG/DMPC membranes. The steps involved in the deconvolution are described in the Methods 
section.  
Figure 7: Titration of excimer formation with DMPG. Perylene-daptomycin was incubated with 
dihexanoyl-PC (20 mM) and calcium (1 mM). A suspension of DMPC/DMPG liposomes was 
added in a stepwise fashion, and the perylene fluorescence emission recorded after each addition. 
The increment in the ratio of the emissions at 521 nm and at 482 nm is plotted as a function of the 
molar ratio of PG to daptomycin. The curve represents a fit to the law of mass action, and the 
straight lines represent the tangents of the fit curve at zero and infinity, respectively.  
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Figure 7
General.  DMF was distilled under reduced pressure from CaH.  All reagents used in 
syntheses were obtained from Aldrich Chemical Co (Milwaukee, Wisc., USA) except for 
1-pyrenebutanoic  acid  succinimidyl  ester  which  was  obtained  from  Anaspec  Inc 
(Freemont, CA, USA).  Deacylated daptomycin bearing a Boc protecting group on the 
ornithine  residue  was  a  gift  from  Cubist  Inc  (Boston,  Mass.,  USA).   Flash 
chromatography  was  performed  using  silica  gel  60Å  (234-400  mesh)  obtained  from 
Silicycle (Laval, Quebec, Canada).  1H NMR was performed on a Bruker Avance 300. 
Chemical shifts (δ) are reported in ppm relative to the internal standard tetramethylsilane 
(TMS).   Negative  ion  electrospray  mass  spectrometry  (-ESIMS) was  performed  on a 
Waters/Micromass  QTOF  Ultima  Global  mass  spectrometer  using  1:1  CH3CN/H2O 
(0.5% ammonium hydroxide)  as solvent.  Analytical  and semi-preparative HPLC was 
performed on a Waters 600E system equipped with Waters 474 scanning fluorescence 
detector (excitation = 365 nm, emission = 460 nm).  Semi-preparative HPLC was performed 
using  a  Higgins  (Higgins  Analytical  Inc.,  Mountainview,  CA.  USA) Proto-200 C-18 
semi-preparative (20 mm x 250 mm) column with a flow rate of 6 mL/min.  Analytical 
HPLC was performed using a Phenomenex (Torrance, CA, USA) Jupiter Proteo C-18 
analytical (4.6 x 250 mm) column with a flow rate of 1 mL/min.
Perylene- and pyrene-daptomycin was prepared according to Scheme 1.  Details of the 
procedure are given in the Methods section of the main text. 
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Scheme 1.  Synthesis of perylene- and pyrene-daptomycin.
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4-(3-Perylenyl)butanoic acid succinimidyl ester.  This compound was prepared using a 
procedure based upon that reported by Oskolkova et al. (1) 4-(3-Perylenyl)butanoic acid 
(0.030g,  0.089  mmol)  was  added  to  a  solution  of  N-hydroxysuccinimide  in 
dichloromethane  (2  mL)  and  cooled  to  0  oC  (ice  bath).   To  this  was  added  N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 0.017 g, 0.098 mmol) 
and a catalytic amount of dimethylaminopyridine (DMAP).  The solution was stirred at 0 
oC for 1h. The ice bath was removed and the solution stirred for an additional 24 h.  The 
solution was diluted with  dichloromethane (10 mL) and washed with sat. brine (3 x 10 
mL).   The organic layer  was dried (Na2SO4)  and concentrated  by rotary evaporation. 
Flash chromatography (40% ethyl acetate, 60% hexane, Rf = 0.3) of the residue gave pure 
4-(3-perylenyl)butanoic acid succinimidyl ester  in  a 90% yield  (0.030 g) as a yellow 
amorphous solid.  1H NMR (CDCl3):  2.22 (quint, 2H, J = 7.9 Hz), 2.73 (t, 2H, J = 6.9 
Hz), 2.87 (s, 4H), 3.17 (t, 2H, J = 7.4 Hz), 7.37 (d, 1H, J = 7.4 Hz), 7.43-7.59 (m, 3H), 
7.66 (d, 1H, J = 3.7 Hz), 7.68 (d, 1H, J = 3.7 Hz), 7.89 (d, 1H, J = 8.5 Hz), 8.10-8.25 (m, 
4H).
Figure S1.  –ESIMS of dap-perylene. The peak with m/z 1784.76 corresponds to the (M-
H)-1 ion.
Figure S2.  Analytical HPLC chromatogram of dap-perylene (tr = 29.5 min) after HPLC 
purification.  Analytical HPLC was performed using a Phenomenex Jupiter Proteo C-18 
analytical column (250 x 4.6 mm), a linear gradient starting with 95% water (0.1% TFA)-
5% acetonitrile  to  100 % acetonitrile  over  50 minutes  with a flow rate  of 1 mL/min 
(excitation = 365 nm, emission = 460 nm).  
Figure S3.  –ESIMS of dap-pyrene. The peak with m/z 1734.75 corresponds to the (M-H)-
1 ion.
Figure S4.  Analytical HPLC chromatogram of dap-pyrene (tr = 26.4 min) after HPLC 
purification.  Analytical HPLC was performed using a Phenomenex Jupiter Proteo C-18 
analytical column (250 x 4.6 mm), a linear gradient starting with 95% water (0.1% TFA)-
5% acetonitrile  to  100 % acetonitrile  over  50 minutes  with a flow rate  of 1 mL/min 
(excitation = 365 nm, emission = 460 nm).  
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